Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric StudyGrégoire Le Meur, Maël Heiblig, Rubio Marie Thérèse et al.|Transplantation and Cellular Therapy|2022Cited by 10
Long-term use of liposomal nebulized amikacin and tedizolid for the treatment of disseminated nocardiosis after allogeneic hematopoietic stem cell transplantationSarah Souèges, Martine Wallon, Claire Triffault-Fillit et al.|European Journal of Clinical Microbiology & Infectious Diseases|2021Cited by 10
Parameters influencing the pharmacokinetics/pharmacodynamics of piperacillin/tazobactam in patients with febrile neutropenia and haematological malignancy: a prospective studyNicolas Benech, Martine Wallon, Oana Dumitrescu et al.|Journal of Antimicrobial Chemotherapy|2019Cited by 6
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDYXavier Thomas, Gilles Salles, Marica Laurino et al.|Mediterranean Journal of Hematology and Infectious Diseases|2020Cited by 5
Epstein-Barr Virus (EBV) Reactivation, Its Treatment with Rituximab and Their Impact on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological MalignanciesMauricette Michallet, Franck‐Emmanuel Nicolini, Mohamad Sobh et al.|Blood|2016Cited by 4